98%
921
2 minutes
20
To examine the trends in melanoma prevalence among U.S. adults from 1999 to 2018, considering the role of skin reaction to sun exposure, body mass index (BMI), age, sex, and race/ethnicity. Cross-sectional analysis using data from the National Health and Nutrition Examination Survey (NHANES) spanning ten continuous 2-year cycles from 1999-2000 to 2017-2018. A nationally representative survey of the U.S. civilian, non-institutionalized population. The study identified significant trends in melanoma prevalence across various demographic groups. A history of severe sunburn with blisters (OR, 3.94; 95% CI, 1.28-12.15) and severe sunburn for a few days with peeling (OR, 4.67; 95% CI, 2.01-10.84) were associated with higher odds of melanoma. Individuals with overweight exhibited a significantly higher prevalence of melanoma (OR, 4.54; 95%CI, 2.36- 8.75), with a clear upward trend over the study period. Non-Hispanic White adults had significantly higher odds of melanoma compared to other racial/ethnic groups (OR, 10.70; 95% CI, 1.44-79.54). Age also influenced melanoma prevalence, with older adults showing the highest prevalence. The findings highlight the significant role of severe sunburns, BMI, age, and race/ethnicity in melanoma prevalence. Public health strategies should focus on sun protection, particularly for those prone to severe sunburns, and address the increasing melanoma rates among individuals with higher BMI. Efforts to reduce disparities in melanoma diagnosis and prevention among racial/ethnic minorities are essential to mitigate this public health burden.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s40615-025-02399-5 | DOI Listing |
Br J Dermatol
September 2025
National Disease Registration Service, Data and Analytics, NHS England, Leeds, UK.
Introduction: Skin cancers primarily affect people of White ethnicity and lighter skin tones, but people of other ethnicities may face diagnostic delays and experience higher mortality, reflecting existing inequities in healthcare. This is the first study showing incidence data from the National Disease Registration Service (NDRS) cancer registry in England for skin cancers stratified by the seven broad ethnic groups.
Methods: We used data from NDRS from 2013-20 to analyse melanoma, acral lentiginous melanoma (ALM), basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), cutaneous T-cell lymphoma (CTCL), and Kaposi sarcoma (KS).
PLoS One
September 2025
Department Chemicals and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Tattoos and permanent make-up (PMU) gain increasing popularity among the general population. There are indications that pigments or their fragments may translocate within the body, however knowledge about possible systemic adverse effects related to tattoos is very limited. We investigated the prevalence of systemic chronic health effects including cardiovascular diseases, cancer and liver toxicity and their relationship with the presence and characteristics of tattoos and PMU as part of the LIFE-Adult-study, a population-based cohort study.
View Article and Find Full Text PDFOncol Res
September 2025
Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, 210042, China.
Introduction: Acral melanoma (AM) is the predominant subtype of cutaneous melanoma in Asian populations, characterized by more aggressive clinical features and limited neoadjuvant therapy response. Centrosomal protein 55 kDa (CEP55) has been implicated in the pathogenesis of various malignancies, but its role in AM remains undefined.
Methods: CEP55 expression in melanoma tissues and cell lines was analyzed by RT-qPCR, Western blotting, and immunohistochemistry (IHC).
Front Immunol
September 2025
Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Background: Neoantigen-based vaccines show promising therapeutic potential in solid tumors such as melanoma, GBM, NSCLC, and CRC. However, clinical responses remain suboptimal in stage IV patients, due to ineffective T-cell function and high tumor burdens. To overcome these limitations, our study investigates a combination strategy using neoantigen peptide vaccines and precision critical lesion radiotherapy (CLERT), which delivers immunomodulatory doses to key tumor regions synergistically enhance immune activation and inhibit progression in multifocal stage IV patients.
View Article and Find Full Text PDFAnn Dermatol Venereol
September 2025
Université Grenoble Alpes, Service de dermatologie, Centre Hospitalier Universitaire, Grenoble, France; UGA/Inserm U 1209/CNRS UMR 5309 Joint Research Center, Institute for Advanced Biosciences, 38700 La Tronche, France.
Background: COVID-19 pandemic had a variable impact on the severity of melanomas.
Objective: To assess the role of the COVID-19 pandemic in France on the severity of melanomas at initial diagnosis.
Methods: New melanoma cases recorded in the French RIC-Mel database were included in a retrospective study spanning three timeframes: pre-COVID (01/01/2018 to 03/16/2020), lockdown (03/17/2020 to 10/05/2020), and the COVID pandemic period (hereafter referred to as "COVID") (11/05/2020 to 30/09/2022).